Entrada Therapeutics, Inc. (TRDA)
NGM – Real vaqt narxi. Valyuta: USD
7.12
+0.12 (1.71%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
7.12
+0.12 (1.71%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Entrada Therapeutics, Inc. klinik bosqichdagi biofarmatsevtika kompaniyasidir bo'lib, u uzoq vaqtdan beri mavjud bo'lmagan deb hisoblangan hujayra ichidagi nishonlarga ta'sir qiluvchi yangi turdagi dori vositalarini yaratish orqali bemorlarning hayotini o'zgartirishni maqsad qiladi. Kompaniyaning Endosomal Escape Vehicle asosidagi terapevtik nomzodlari noyob terapevtik vositalarga asoslangan; nerv-mushak va irsiy ko'z kasalliklarini davolash uchun genetik dorilarni ishlab chiqish bo'yicha mustahkam portfel. Uning preklinik mahsulotlari ENTR-601-44; ENTR-601-45; va VX-670ni o'z ichiga oladi. Kompaniya ilgari CycloPorters, Inc. nomi bilan tanilgan va 2017-yil oktyabr oyida Entrada Therapeutics, Inc. nomini o'zgartirgan. Entrada Therapeutics, Inc. 2016-yilda tashkil etilgan va shtab-kvartirasi Boston, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Jared Cohen J.D., Ph.D. | General Counsel |
| Dr. Natarajan Sethuraman Ph.D. | President of Research & Development |
| Mr. Dipal Doshi | CEO & Director |
| Mr. Kevin Healy Ph.D. | Senior Vice President of Regulatory Affairs |
| Mr. Kory James Wentworth CPA | CFO & Treasurer |
| Mr. Nathan J. Dowden | President & COO |
| Ms. Karla MacDonald | Chief Corporate Affairs Officer |
| Ms. Kerry Robert M.S. | Senior Vice President of People |
| Sandeep Basnet | Head of Information Technology |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 8-K | trda-20260507.htm |
| 2026-05-07 | 10-Q | trda-20260331.htm |
| 2026-04-29 | DEFA14A | tm2613037d1_defa14a.htm |
| 2026-04-24 | DEFA14A | entradatherapeuticsinc-202.htm |
| 2026-04-24 | DEF 14A | trda-20260424.htm |
| 2026-02-26 | 10-K | trda-20251231.htm |
| 2026-01-08 | 8-K | trda-20260108.htm |
| 2025-12-01 | CORRESP | filename1.htm |
| 2025-11-06 | S-3 | tm2530185d1_s3.htm |
| 2025-11-06 | 8-K | trda-20251106.htm |